View Older Stories
-
Exclusive: Shareholder revolt threatens Alcon's takeover of STAAR Surgical
-
CorMedix completes Melinta acquisition, raises 2025 revenue guidance
-
Form N-PX DEERFIELD MANAGEMENT For: Jun 30
-
Form 13F-HR DEERFIELD MANAGEMENT For: Jun 30
-
BBOT begins trading on Nasdaq after $382M SPAC merger completion
-
CorMedix to acquire Melinta Therapeutics for $300 million
-
CorMedix to acquire Melinta Therapeutics for $300 million
-
Form 4 Nuvalent, Inc. For: Jun 18 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Form 4 Larimar Therapeutics, For: May 13 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Form 13F-HR DEERFIELD MANAGEMENT For: Mar 31
-
Twist Bioscience Corporation (TWST) Spins Out DNA Data Storage as Independent Company
-
Form 4 BiomX Inc. For: Apr 14 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
The Oncology Institute (TOI) Announces $16.5M Private Placement
-
BridgeBio Oncology Therapeutics to go Public via Merger with Helix Acquisition Cp II (HLXB)
-
Form 13F-HR DEERFIELD MANAGEMENT For: Dec 31
-
Form 4 Acutus Medical, Inc. For: Jan 27 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
AbbVie (ABBV) and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology
-
Singular Genomics Systems (OMIC) Acquired by Deerfield for $20/sh Cash
-
Form 13F-HR DEERFIELD MANAGEMENT For: Sep 30
-
Form 4 ARS Pharmaceuticals, For: Nov 11 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Aileron Therapeutics (ALRN) and Advancium Health Network Announce an Exclusive Option Agreement for the Acquisition of ALRN-6924 for Retinoblastoma
-
Aerovate Therapeutics (AVTE) and Jade Biosciences Announce Merger Agreement
-
Brookdale Senior Living (BKD) to acquire 41 currently leased communities
-
Form 3 Bicara Therapeutics Inc. For: Sep 12 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Singular Genomics Systems (OMIC) Receives Non-Binding Acquisition Proposal from Deerfield
-
Singular Genomics Systems (OMIC) receives takeover proposal from Deerfield
-
Horizon Technology Finance (HRZN) Provides $35 Million Venture Loan Facility to Vesta Healthcare
-
Form N-PX DEERFIELD MANAGEMENT For: Jun 30
-
Form 13F-HR DEERFIELD MANAGEMENT For: Jun 30
-
Day One Biopharmaceuticals (DAWN) Announces 10.55M Share Offering at $14.50/sh
-
Form 4 BiomX Inc. For: Jul 11 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Mereo BioPharma (MREO) Prices 12.53M Share Offering at $3.99/sh
-
Advanced Medicine Partners Executes Additional $32 Million Financing Agreement led by Deerfield Management, Appoints Two New Board Members
-
Deerfield Management Welcomes Frank Nestle, MD, FMedSci, as Partner and Chief Executive Officer of Therapeutic Discovery and Development
-
Cohere Health, Medical Mutual, and Rhyme Partner on Utilization Management Transformation
-
Form 4 Larimar Therapeutics, For: May 29 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Cure® Unveils US Biotech Industry Benchmark Report 2024: Dark Days of 2023 are Over
-
Adela to Present Data Supporting Use of its Tissue-Agnostic MRD Assay for Recurrence Prediction and Monitoring in Patients with Head & Neck Cancer at the American Society of Clinical Oncology 2024
-
Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance Pipeline
-
BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates
-
Meditrina Announces 510(k) Clearance for Gen 2 Bipolar RF Hysteroscopy System and Aveta Glo Bipolar RF Device
-
Element Science Appoints Lee Smith, Jr. as the Company’s First Head of Commercial
-
Form 13F-HR DEERFIELD MANAGEMENT For: Mar 31
-
Cohere Health Launches Early Trend Signal Intelligence to Predict Utilization Trends Earlier than Claims-based Methods
-
One-Year Results of the DETOUR2 Trial published in the Journal of Vascular Surgery (JVS)
-
Apertura Gene Therapy Showcases Advancements in Capsid Engineering Platform in Presentations at ASGCT Annual Meeting
-
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO
-
Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates
-
Deerfield Management and Deerfield Foundation Announce Second Annual AML Summit and Recipients of American Society of Hematology (ASH) Peter Steelman Scholar Award
-
BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update

